{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:05:09Z","timestamp":1794650709920,"version":"4.9.1"},"reference-count":88,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The beginning of the modern era of blood transfusion coincided with World War II and the resultant need for massive blood replacement. Soon thereafter, the hazards of transfusion, particularly hepatitis and hemolytic transfusion reactions, became increasingly evident. The past half century has seen the near eradication of transfusion-associated hepatitis as well as the emergence of multiple new pathogens, most notably HIV. Specific donor screening assays and other interventions have minimized, but not eliminated, infectious disease transmission. Other transfusion hazards persist, including human error resulting in the inadvertent transfusion of incompatible blood, acute and delayed transfusion reactions, transfusion-related acute lung injury (TRALI), transfusion-associated graft-versus-host disease (TA-GVHD), and transfusion-induced immunomodulation. These infectious and noninfectious hazards are reviewed briefly in the context of their historical evolution.<\/jats:p>","DOI":"10.1182\/blood-2008-07-077370","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T19:48:45Z","timestamp":1222112925000},"page":"2617-2626","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":280,"title":["The hazards of blood transfusion in historical perspective"],"prefix":"10.1182","volume":"112","author":[{"given":"Harvey J.","family":"Alter","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey G.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714580361800_B1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u201cnew\u201d antigen in leukemia sera.","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"key":"2019111714580361800_B2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/194656a0","article-title":"Antigen polymorphism of a low-density beta lipoprotein. Allotypy in human serum.","volume":"194","author":"Blumberg","year":"1962","journal-title":"Nature"},{"key":"2019111714580361800_B3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jama.1968.03140360030006","article-title":"Anicteric hepatitis associated with Australia antigen: occurrence in patients with Down's syndrome.","volume":"205","author":"Sutnick","year":"1968","journal-title":"JAMA"},{"key":"2019111714580361800_B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-70-1-55","article-title":"Australia antigen and acute viral hepatitis.","volume":"70","author":"London","year":"1969","journal-title":"Ann Intern Med"},{"key":"2019111714580361800_B5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM197004302821801","article-title":"Immunologic distinction between infectious and serum hepatitis.","volume":"282","author":"Prince","year":"1970","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.1970.03170020025005","article-title":"Post-transfusion hepatitis after open heart operations: incidence after the administration of blood from commercial and volunteer donor populations.","volume":"211","author":"Walsh","year":"1970","journal-title":"JAMA"},{"key":"2019111714580361800_B7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/0003-4819-77-5-691","article-title":"Postransfusion hepatitis after exclusion of the commercial and hepatitis B antigen positive donor.","volume":"77","author":"Alter","year":"1972","journal-title":"Ann Intern Med"},{"key":"2019111714580361800_B8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.182.4116.1026","article-title":"Hepatitis A detection by immune electron microscopy of a virus-like antigen associated with acute illness.","volume":"182","author":"Feinstone","year":"1973","journal-title":"Science"},{"key":"2019111714580361800_B9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM197504102921502","article-title":"Transfusion-associated hepatitis not due to viral hepatitis type A or B.","volume":"292","author":"Feinstone","year":"1975","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(78)90131-9","article-title":"Transmissible agent in \u201cnon-A, non-B\u201d hepatitis.","volume":"1","author":"Alter","year":"1978","journal-title":"Lancet"},{"key":"2019111714580361800_B11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(78)90132-0","article-title":"Transmission of non-A, non-B hepatitis from man to chimpanzee.","volume":"1","author":"Tabor","year":"1978","journal-title":"Lancet"},{"key":"2019111714580361800_B12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/IAI.41.2.816-821.1983","article-title":"Inactivation of hepatitis B virus and non-A, non-B virus by chloroform.","volume":"4","author":"Feinstone","year":"1983","journal-title":"Infect Immun"},{"key":"2019111714580361800_B13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/infdis\/156.4.636","article-title":"Determining the size of non-A, non-B hepatitis virus by filtration.","volume":"156","author":"He","year":"1987","journal-title":"J Infect Dis"},{"key":"2019111714580361800_B14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0016-5085(85)90150-7","article-title":"Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule forming agent is a small enveloped virus.","volume":"88","author":"Bradley","year":"1985","journal-title":"Gastroenterology"},{"key":"2019111714580361800_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-91-1-1","article-title":"The chronic sequelae of non-A, non-B hepatitis.","volume":"91","author":"Berman","year":"1979","journal-title":"Ann Intern Med"},{"key":"2019111714580361800_B16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jama.1981.03320060032017","article-title":"The relationship of donor transaminase (ALT) to recipient hepatitis: Impact on blood transfusion services.","volume":"246","author":"Alter","year":"1981","journal-title":"JAMA"},{"key":"2019111714580361800_B17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-104-4-488","article-title":"Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.","volume":"104","author":"Koziol","year":"1986","journal-title":"Ann Intern Med"},{"key":"2019111714580361800_B18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"2019111714580361800_B19","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM198911303212202","article-title":"Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.","volume":"321","author":"Alter","year":"1989","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B20","first-page":"250","article-title":"Pneumocystis pneumonia \u2013 Los Angeles.","volume":"30","author":"Centers for Disease Control","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019111714580361800_B21","first-page":"294","article-title":"Update on Kaposi's sarcoma and opportunistic infections in previously healthy persons \u2013 United States.","volume":"31","author":"Centers for Disease Control","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019111714580361800_B22","first-page":"365","article-title":"Pneumocystis carinii pneumonia among persons with hemophilia A.","volume":"31","author":"Centers for Disease Control","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019111714580361800_B23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(83)92082-2","article-title":"Acquired immunodeficiency in an infant: possible transmission by means of blood products.","volume":"1","author":"Ammann","year":"1983","journal-title":"Lancet"},{"key":"2019111714580361800_B24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1537-2995.1987.27587320525.x","article-title":"Estimating the risks of transfusion-associated acquired immune deficiency syndrome and human immunodeficiency virus infection.","volume":"27","author":"Peterman","year":"1987","journal-title":"Transfusion"},{"key":"2019111714580361800_B25","first-page":"37","article-title":"Transmission of human immunodeficiency virus (HIV) by blood and blood components.","volume-title":"Transfusion-Transmitted Viral Diseases","author":"Allen","year":"1987"},{"key":"2019111714580361800_B26","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1001\/jama.1985.03350470061021","article-title":"Human T-lymphotropic retrovirus type III\/lymphadenopathy-associated virus antibody:association with hemophiliac's immune status and blood component usage.","volume":"252","author":"Jason","year":"1985","journal-title":"JAMA"},{"key":"2019111714580361800_B27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"key":"2019111714580361800_B28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.6200936","article-title":"Frequent detection and isolation of a cytopathic retroviris (HTLV-III) from patients with AIDS and at risk for AIDS.","volume":"224","author":"Gallo","year":"1984","journal-title":"Science"},{"issue":"2","key":"2019111714580361800_B29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminhematol.2006.02.003","article-title":"The precautionary principle and emerging biologic risks: lessons from human immunodeficiency virus in blood products.","volume":"43","author":"Stoto","year":"2006","journal-title":"Semin Hematol"},{"key":"2019111714580361800_B30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","article-title":"Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiologic survey.","volume":"358","author":"Mostashari","year":"2001","journal-title":"Lancet"},{"key":"2019111714580361800_B31","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of west Nile virus from an organ donor to four transplant recipients.","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B32","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of west Nile virus through blood transfusion in the United States in 2002.","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa044333","article-title":"West Nile virus among blood donors in the United States, 2003 and 2004.","volume":"353","author":"Stramer","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.seminhematol.2006.09.016","article-title":"Emerging infectious diseases that threaten the blood supply.","volume":"44","author":"Alter","year":"2007","journal-title":"Semin Hematol"},{"key":"2019111714580361800_B35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2516.2007.01572.x","article-title":"Creutzfeldt-Jakob disease: reflections on risk from blood product therapy.","volume":"13","author":"Brown","year":"2007","journal-title":"Haemophilia"},{"key":"2019111714580361800_B36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmrv.2007.09.003","article-title":"Transfusion transmission of human prion diseases.","volume":"22","author":"Zou","year":"2008","journal-title":"Transfus Med Rev"},{"key":"2019111714580361800_B37","article-title":"The blood bank and the techniques and therapeutics of transfusion.","author":"Kilduffe","year":"1942"},{"key":"2019111714580361800_B38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1537-2995.1969.tb04909.x","article-title":"Transmission of syphilis by fresh blood components.","volume":"9","author":"Chambers","year":"1969","journal-title":"Transfusion"},{"key":"2019111714580361800_B39","first-page":"273","article-title":"A study of bacteria implicated in transfusion reactions and of bacteria isolated from blood products.","volume":"42","author":"Pittman","year":"1953","journal-title":"J Lab Clin Med"},{"key":"2019111714580361800_B40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1537-2995.2001.41121493.x","article-title":"Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.","volume":"41","author":"Kuehnert","year":"2001","journal-title":"Transfusion"},{"key":"2019111714580361800_B41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1537-2995.2006.00790.x","article-title":"Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004.","volume":"46","author":"Yomtovian","year":"2006","journal-title":"Transfusion"},{"key":"2019111714580361800_B42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1537-2995.2001.41070857.x","article-title":"Single-donor platelets reduce the risk of septic platelet transfusion reactions.","volume":"41","author":"Ness","year":"2001","journal-title":"Transfusion"},{"key":"2019111714580361800_B43","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1537-2995.2007.01248.x","article-title":"Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).","volume":"47","author":"Eder","year":"2007","journal-title":"Transfusion"},{"key":"2019111714580361800_B44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.5858\/2007-131-719-PITDSF","article-title":"Pathogen inactivation: the definitive safeguard for the blood supply.","volume":"131","author":"Bryant","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2019111714580361800_B45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/09595287180090P107","article-title":"Experiments on the transfusion of blood by the syringe.","volume":"9","author":"Blundell","year":"1818","journal-title":"Med-Chir Trans"},{"key":"2019111714580361800_B46","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/jama.1913.04350250024007","article-title":"Accidents in transfusion. Their prevention by preliminary blood examination: based on experience of one hundred and twenty-eight transfusions.","volume":"61","author":"Ottenberg","year":"1913","journal-title":"JAMA"},{"key":"2019111714580361800_B47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcp\/13.2.74","article-title":"Hemolytic transfusion reactions. IV. Differential diagnosis: \u201cdangerous universal donor\u201d or intragroup incompatibility.","volume":"13","author":"Wiener","year":"1943","journal-title":"Am J Clin Pathol"},{"key":"2019111714580361800_B48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1046\/j.1537-2995.2000.40101207.x","article-title":"Transfusion errors in New York State: an analysis of 10 years' experience.","volume":"40","author":"Linden","year":"2000","journal-title":"Transfusion"},{"key":"2019111714580361800_B49","article-title":"Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal years 2005 and 2006.","author":"Center for Biologics Evaluation and Research","year":"2008"},{"key":"2019111714580361800_B50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1423-0410.2003.00313.x","article-title":"An international study of the performance of sample collection from patients.","volume":"85","author":"Dzik","year":"2003","journal-title":"Vox Sang"},{"key":"2019111714580361800_B51","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1537-2995.2000.40080902.x","article-title":"Acute intravascular hemolysis secondary to out-of-group platelet transfusion.","volume":"40","author":"Larsson","year":"2000","journal-title":"Transfusion"},{"key":"2019111714580361800_B52","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V95.8.2523","article-title":"Acute onset hemoglobinemia and\/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.","volume":"95","author":"Gaines","year":"2000","journal-title":"Blood"},{"key":"2019111714580361800_B53","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1542\/peds.111.6.e661","article-title":"Delayed hemolytic transfusion reaction\/hyperhemolysis syndrome in children with sickle cell disease.","volume":"111","author":"Talano","year":"2003","journal-title":"Pediatrics"},{"key":"2019111714580361800_B54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM196607212750305","article-title":"Isoimmunization after multiple transfusions.","volume":"275","author":"Lostumbo","year":"1966","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B55","first-page":"378","article-title":"Hemolytic transfusion reaction: recent experience in a large blood bank.","volume":"53","author":"Pineda","year":"1978","journal-title":"Mayo Clin Proc"},{"key":"2019111714580361800_B56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7326\/0003-4819-93-2-231","article-title":"Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.","volume":"93","author":"Diamond","year":"1980","journal-title":"Ann Intern Med"},{"key":"2019111714580361800_B57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1537-2995.1999.39101097.x","article-title":"Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.","volume":"39","author":"Pineda","year":"1999","journal-title":"Transfusion"},{"key":"2019111714580361800_B58","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease: The Cooperative Study of Sickle Cell Disease.","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"2019111714580361800_B59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jama.1957.02980250053013","article-title":"Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets.","volume":"165","author":"Brittingham","year":"1957","journal-title":"JAMA"},{"key":"2019111714580361800_B60","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1159\/000465160","article-title":"Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes.","volume":"11","author":"Perkins","year":"1966","journal-title":"Vox Sang"},{"key":"2019111714580361800_B61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1046\/j.1537-2995.1992.32692367210.x","article-title":"Is the febrile response to transfusion due to donor or recipient cytokine?","volume":"32","author":"Dzik","year":"1992","journal-title":"Transfusion"},{"key":"2019111714580361800_B62","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000460903","article-title":"Febrile transfusion reaction: what blood component should be given next?","volume":"42","author":"Menitove","year":"1982","journal-title":"Vox Sang"},{"key":"2019111714580361800_B63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1537-2995.2002.00036.x","article-title":"Signs and symptoms associated with the transfusion of WBC-reduced RBCs and non-WBC-reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study.","volume":"42","author":"Lane","year":"2002","journal-title":"Transfusion"},{"key":"2019111714580361800_B64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"key":"2019111714580361800_B65","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1537-2995.2003.00529.x","article-title":"Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.","volume":"43","author":"Enright","year":"2003","journal-title":"Transfusion"},{"key":"2019111714580361800_B66","first-page":"141","article-title":"Thymic involution mimicking thymic dysplasia: a consequence of transfusion-induced graft versus host disease in a premature infant.","volume":"104","author":"Seemayer","year":"1980","journal-title":"Arch. Pathol Lab Med"},{"key":"2019111714580361800_B67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1537-2995.1996.36296181922.x","article-title":"Posttransfusion graft-versus-host disease in Japanese newborns.","volume":"36","author":"Ohto","year":"1996","journal-title":"Transfusion"},{"key":"2019111714580361800_B68","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM196510282731803","article-title":"Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children:. probable human runt disease.","volume":"273","author":"Hathaway","year":"1965","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B69","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.0041-1132.2003.00579.x","article-title":"Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.","volume":"43","author":"Leitman","year":"2003","journal-title":"Transfusion"},{"key":"2019111714580361800_B70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0887-7963(96)80121-0","article-title":"Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients.","volume":"10","author":"Ohto","year":"1996","journal-title":"Transfus Med Rev"},{"key":"2019111714580361800_B71","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2141.1994.tb05093.x","article-title":"Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.","volume":"88","author":"Maung","year":"1994","journal-title":"Br J Haematol"},{"key":"2019111714580361800_B72","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1537-2995.2006.00853.x","article-title":"Transfusion-associated graft-versus-host disease: less fresh blood and more gray (Gy) for an aging population.","volume":"46","author":"Klein","year":"2006","journal-title":"Transfusion"},{"key":"2019111714580361800_B73","first-page":"1224","article-title":"Hypothesis: absence of graft-versus-host disease in AIDS is a consequence of HIV-1 infection of CD4+ T cells.","volume":"6","author":"Ammann","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019111714580361800_B74","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199402103300605","article-title":"Brief report: polymorphic microsatellite markers for the diagnosis of graft-versus-host disease.","volume":"330","author":"Wang","year":"1994","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B75","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood.V93.9.3140","article-title":"Prevention of transfusion-associated graft-versus-host disease by photochemical treatment.","volume":"93","author":"Grass","year":"1999","journal-title":"Blood"},{"key":"2019111714580361800_B76","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood.V83.6.1683.1683","article-title":"Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease.","volume":"83","author":"Pelszynski","year":"1994","journal-title":"Blood"},{"key":"2019111714580361800_B77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199002013220507","article-title":"Transfusion-associated graft-versus-host disease.","volume":"323","author":"Anderson","year":"1990","journal-title":"N Engl J Med"},{"key":"2019111714580361800_B78","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1182\/blood.V5.12.1099.1099","article-title":"Transfusion of leukemic leukocytes in man; hematologic and physiologic changes.","volume":"5","author":"Lanman","year":"1950","journal-title":"Blood"},{"key":"2019111714580361800_B79","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: definition and review.","volume":"33","author":"Toy","year":"2005","journal-title":"Crit Care Med"},{"key":"2019111714580361800_B80","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000478325","article-title":"Immunologic studies on leukocytes.","volume":"2","author":"Brittingham","year":"1957","journal-title":"Vox Sang"},{"key":"2019111714580361800_B81","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","article-title":"Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.","volume":"25","author":"Popovsky","year":"1985","journal-title":"Transfusion"},{"key":"2019111714580361800_B82","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-73-5-689","article-title":"Pulmonary infiltrates associated with leukoagglutinin transfusion reactions.","volume":"73","author":"Ward","year":"1970","journal-title":"Ann Intern Med"},{"key":"2019111714580361800_B83","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1001\/jama.287.15.1968","article-title":"Transfusion-related acute lung injury: report of a clinical look-back investigation.","volume":"287","author":"Kopko","year":"2002","journal-title":"JAMA"},{"key":"2019111714580361800_B84","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1537-2995.2006.01148.x","article-title":"The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions.","volume":"47","author":"Fadeyi","year":"2007","journal-title":"Transfusion"},{"key":"2019111714580361800_B85","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0140-6736(05)61049-5","article-title":"Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies.","volume":"352","author":"Dooren","year":"1998","journal-title":"Lancet"},{"key":"2019111714580361800_B86","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood-2006-05-025106","article-title":"Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model.","volume":"109","author":"Silliman","year":"2007","journal-title":"Blood"},{"key":"2019111714580361800_B87","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1177\/030089160108700221","article-title":"The immunomodulatory effects of blood transfusion.","volume":"87","author":"Klein","year":"2001","journal-title":"Tumori"},{"key":"2019111714580361800_B88","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMoa070403","article-title":"Duration of red-cell storage and complications after cardiac surgery.","volume":"358","author":"Koch","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/7\/2617\/1301976\/zh801908002617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/7\/2617\/1301976\/zh801908002617.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:38:21Z","timestamp":1631839101000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/7\/2617\/24725\/The-hazards-of-blood-transfusion-in-historical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-077370","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}